Latin America & Caribbean

Bolsonaro vetoes Brazil’s first-of-a-kind compulsory tech transfer law

The president’s rejection of forced know-how licensing will now be reviewed by the country’s Congress, but a new patent suspension regime is set to come into force

Bolsonaro vetoes Brazil’s first-of-a-kind compulsory tech transfer law
Brazil on the cusp of passing landmark compulsory technology transfer law
19 Aug 2021

Brazil on the cusp of passing landmark compulsory technology transfer law

Life sciences innovators may be compelled to hand over trade secrets, data and biological materials under legislation that now only requires President Bolsonaro’s signature to become law

How innovators hit by Brazil’s shortened patent terms can mitigate their impact
11 Aug 2021

How innovators hit by Brazil’s shortened patent terms can mitigate their impact

The Long Read: Since the country's Supreme Court curtailed thousands of rights in May, those who hold them have been scrambling for ways to maintain their income streams. Ricardo Nunes explores the best options for those affected by the changes

Latest

View all
22 Sep 2021

INPI introduces new proceedings now that ANVISA´s prior approval for pharma patents is over

Brazil’s recent overhaul of its procedures for handling patents is well underway. So far it is yielding positive results, especially with regard to pharmaceutical and biotechnology patents. Read more

9 Sep 2021

IAM Patent 1000 insights

Read more

8 Sep 2021

Pharmaceutical patent applications are no longer subject to ANVISA’s prior approval

As the Brazilian Ministry of Economy looks to boost the country’s market by introducing new legal measures, pharmaceutical patent holders and future applicants will no longer be required to go through two regulatory bodies. This should make obtaining patent approval in Brazil a much smoother process. Read more

11 Aug 2021

Moving towards the compulsory licensing for exploiting Brazilian pharmaceutical patents for the treatment of covid-19

The House of Representatives has approved draft bill 12/2021, with some amendments. The bill creates a two-step compulsory licensing process and amends the provisions of the Brazilian Patent Statue (9.279/1996) on compulsory licensing of patents in cases of national emergency or public interest. Read more

Designs

View all
10 Aug 2021

FC Barcelona faces possible €137 million drop in brand value in wake of Messi’s departure

The Argentine superstar is also IP-savvy, with a trademark portfolio far bigger than any of his rivals for the crown of the world's best footballer Read more

28 Oct 2020

Help us to identify the world's leading IP strategists

The research process for the IAM Strategy 300 2021 is now underway and we are inviting nominations as we decide who should be included Read more

12 Oct 2020

What world class IP management looks like

On top of high-quality, day-to-day performance in areas such as prosecution, litigation and licensing, there are three essential elements an in-house function requires to be part of the elite Read more

19 Jun 2020

The advantages and disadvantages of WIPO PROOF

The World Intellectual Property Organization rolled out its new timestamping solution in May and while it has a lot going for it, there are downsides too Read more

Finance

View all
10 Aug 2021

FC Barcelona faces possible €137 million drop in brand value in wake of Messi’s departure

The Argentine superstar is also IP-savvy, with a trademark portfolio far bigger than any of his rivals for the crown of the world's best footballer Read more

26 Mar 2020

Final call to take part in this year’s IAM benchmarking survey

Help us to identify the key trends currently shaping the global IP market Read more

18 Mar 2020

Help us map the latest developments in the global IP market

There’s not long left to answer our annual IP benchmarking survey Read more

6 Mar 2020

Notice of postponement - IPBC Europe 2020 and IP Risk Management Europe 2020

New dates for both events, which had been scheduled to take place in the last week of March, will be announced as soon as possible Read more

Frand/SEPS

View all
4 Jan 2021

The big IP stories you’ll be reading about in 2021

The IAM editorial team identifies what could be this year’s pivotal developments in the global IP market Read more

12 Aug 2020

Meet the new faces in the IP Hall of Fame

This year’s inductees share what it takes to become the best of the best Read more

11 Jun 2020

We name the world's top patent lawyers, attorneys, practices and firms

The 2020 edition of the IAM Patent 1000 features in-depth analysis of the markets in 48 key jurisdictions and is based on thousands of submissions, interviews and client references Read more

1 Apr 2020

From the IAM archive - setting the standard

A look back into our 17-year back catalogue at some of the outstanding content we have published on this vital subject Read more

Law & Policy

View all
13 May 2021

Brazil shortens term of thousands of pharma and medical device patents

Life sciences IP owners feel the full force of a landmark Supreme Court judgment Read more

4 May 2021

Brazilian Senate passes compulsory covid-19 know-how licensing bill

Vaccine owners may be forced to hand over trade secrets or have their patents cancelled under legislation endorsed by the upper house of the country’s Congress Read more

13 Apr 2021

Brazil suspends drug patent extensions and reschedules key Supreme Court hearing for tomorrow

Long-running constitutional challenge putting 40% of patents at-risk set to be resolved, but further delays are possible Read more

4 Feb 2021

UK plan to join CPTPP raises questions about European Patent Organisation membership

On the face of it, the Comprehensive and Permissive Trans Pacific Partnership’s provisions on the grace period run contrary to those that apply in the EPC Read more

Litigation

View all
27 May 2021

Brazil – southern appeal

Read more

13 May 2021

Brazil shortens term of thousands of pharma and medical device patents

Life sciences IP owners feel the full force of a landmark Supreme Court judgment Read more

22 Mar 2021

Thousands of patents at risk of cancellation in Brazil

A constitutional challenge before the Supreme Court that seeks to expunge over 35% of active Brazilian grants, as well as more than 10,000 pending applications, is scheduled to be heard in April Read more

4 Jan 2021

The big IP stories you’ll be reading about in 2021

The IAM editorial team identifies what could be this year’s pivotal developments in the global IP market Read more

Market Developments

View all
18 Mar 2021

Another brick in the wall towards patents becoming fully-fledged assets

Announcing the creation of SPIF - a non-partisan, open standard, human readable solution for uniquely identifying patent assets that is consistent with existing formats Read more

4 Jan 2021

The big IP stories you’ll be reading about in 2021

The IAM editorial team identifies what could be this year’s pivotal developments in the global IP market Read more

12 Oct 2020

What world class IP management looks like

On top of high-quality, day-to-day performance in areas such as prosecution, litigation and licensing, there are three essential elements an in-house function requires to be part of the elite Read more

22 Sep 2020

EPO plant patent decision imperils businesses like ours, says Bayer’s head of IP

Joerg Thomaier tells IAM that the Enlarged Board of Appeal got it wrong in a recent controversial ruling, but says the case is now closed and companies have to learn to live with it Read more

Non-Practising Entities

View all
11 Jun 2020

We name the world's top patent lawyers, attorneys, practices and firms

The 2020 edition of the IAM Patent 1000 features in-depth analysis of the markets in 48 key jurisdictions and is based on thousands of submissions, interviews and client references Read more

8 Jun 2020

Benchmarking 2020 – Europe holds its lead but honeymoon might be over for USPTO head

Our annual snapshot of the industry keeps the EPO at the top of the big five but suggests that the shine may have come off Andrei Iancu’s reign Read more

21 May 2020

Global calls for compulsory covid-19 patent licensing build

Scrutiny of biopharma innovators’ coronavirus IP strategies will continue to intensify in coming months as concerns mount about access to treatments Read more

9 Apr 2020

World leaders hatch further plans for accessibility of covid-19 IP rights

WHO to establish voluntary patent pool, while Greek Prime Minister calls for EU to buy rights to vaccines and tests Read more

Patent Pools

View all
18 Jun 2020

Takeda offloads yet more “non-core” assets with other deals likely to follow

The Japanese big pharma continues to divest drug rights to pay down its debt and fund desperately needed innovation Read more

11 Jun 2020

We name the world's top patent lawyers, attorneys, practices and firms

The 2020 edition of the IAM Patent 1000 features in-depth analysis of the markets in 48 key jurisdictions and is based on thousands of submissions, interviews and client references Read more

21 May 2020

Global calls for compulsory covid-19 patent licensing build

Scrutiny of biopharma innovators’ coronavirus IP strategies will continue to intensify in coming months as concerns mount about access to treatments Read more

9 Apr 2020

World leaders hatch further plans for accessibility of covid-19 IP rights

WHO to establish voluntary patent pool, while Greek Prime Minister calls for EU to buy rights to vaccines and tests Read more

Patents Law

View all
27 May 2021

Brazil – southern appeal

Read more

13 May 2021

Brazil shortens term of thousands of pharma and medical device patents

Life sciences IP owners feel the full force of a landmark Supreme Court judgment Read more

4 May 2021

Brazilian Senate passes compulsory covid-19 know-how licensing bill

Vaccine owners may be forced to hand over trade secrets or have their patents cancelled under legislation endorsed by the upper house of the country’s Congress Read more

13 Apr 2021

Brazil suspends drug patent extensions and reschedules key Supreme Court hearing for tomorrow

Long-running constitutional challenge putting 40% of patents at-risk set to be resolved, but further delays are possible Read more

Strategy

View all
18 Mar 2021

Another brick in the wall towards patents becoming fully-fledged assets

Announcing the creation of SPIF - a non-partisan, open standard, human readable solution for uniquely identifying patent assets that is consistent with existing formats Read more

4 Jan 2021

The big IP stories you’ll be reading about in 2021

The IAM editorial team identifies what could be this year’s pivotal developments in the global IP market Read more

28 Oct 2020

Help us to identify the world's leading IP strategists

The research process for the IAM Strategy 300 2021 is now underway and we are inviting nominations as we decide who should be included Read more

12 Oct 2020

What world class IP management looks like

On top of high-quality, day-to-day performance in areas such as prosecution, litigation and licensing, there are three essential elements an in-house function requires to be part of the elite Read more

Technology Licensing

View all
4 May 2021

Brazilian Senate passes compulsory covid-19 know-how licensing bill

Vaccine owners may be forced to hand over trade secrets or have their patents cancelled under legislation endorsed by the upper house of the country’s Congress Read more

18 Mar 2021

Another brick in the wall towards patents becoming fully-fledged assets

Announcing the creation of SPIF - a non-partisan, open standard, human readable solution for uniquely identifying patent assets that is consistent with existing formats Read more

19 Jan 2021

Six life sciences IP dealmaking trends to watch out for in 2021

Despite a turbulent 2020 for pharma transactions, it is possible to discern a few patterns for activity in the market this year Read more

12 Oct 2020

What world class IP management looks like

On top of high-quality, day-to-day performance in areas such as prosecution, litigation and licensing, there are three essential elements an in-house function requires to be part of the elite Read more

Trade Secrets

View all
28 Oct 2020

Help us to identify the world's leading IP strategists

The research process for the IAM Strategy 300 2021 is now underway and we are inviting nominations as we decide who should be included Read more

12 Oct 2020

What world class IP management looks like

On top of high-quality, day-to-day performance in areas such as prosecution, litigation and licensing, there are three essential elements an in-house function requires to be part of the elite Read more

3 Sep 2020

Brazil’s first national IP strategy heralds benefits for biopharma innovators

Plans are afoot to review several contentious life sciences patent issues in Latin America’s largest economy Read more

19 Jun 2020

The advantages and disadvantages of WIPO PROOF

The World Intellectual Property Organization rolled out its new timestamping solution in May and while it has a lot going for it, there are downsides too Read more

Valuation

View all
19 Jan 2021

Six life sciences IP dealmaking trends to watch out for in 2021

Despite a turbulent 2020 for pharma transactions, it is possible to discern a few patterns for activity in the market this year Read more

9 Sep 2020

The top 10 takeaways from this year’s Global Innovation Index

The latest edition of the annual WIPO publication reveals that Europe and North America still lead despite rising innovation levels in Asia Read more

18 Jun 2020

Takeda offloads yet more “non-core” assets with other deals likely to follow

The Japanese big pharma continues to divest drug rights to pay down its debt and fund desperately needed innovation Read more

21 May 2020

Global calls for compulsory covid-19 patent licensing build

Scrutiny of biopharma innovators’ coronavirus IP strategies will continue to intensify in coming months as concerns mount about access to treatments Read more